0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meropenem Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-35F10058
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Meropenem Injection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Meropenem Injection Market Research Report 2025

Code: QYRE-Auto-35F10058
Report
July 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Meropenem Injection Market

The global market for Meropenem Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
It is suitable for infections caused by single or multiple bacteria sensitive to meropenem in adults and children, including pneumonia, urinary tract infections, and gynecological infections.
North American market for Meropenem Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Meropenem Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Meropenem Injection include Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Fresenius Kabi, Mylan, Sagent Pharmaceuticals, Bionova Scientific, Macleods Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meropenem Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meropenem Injection.
The Meropenem Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meropenem Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meropenem Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Meropenem Injection Market Report

Report Metric Details
Report Name Meropenem Injection Market
Segment by Type
  • 0.25g/vial
  • 0.5g/vial
  • 1g/vial
Segment by Application
  • Hospital
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Fresenius Kabi, Mylan, Sagent Pharmaceuticals, Bionova Scientific, Macleods Pharmaceuticals, Johnlee Pharmaceuticals, Xinya Pharm, PKU HealthCare, United Laboratories, CSPC Group, Zhejiang Hisun Pharmaceutical, Luoxin Pharmaceutical, Hainan Haiyao Co., Ltd., Shenzhen Haibin Pharmaceutical, Chongqin Shenghuaxi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Meropenem Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Meropenem Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Meropenem Injection Market report?

Ans: The main players in the Meropenem Injection Market are Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Fresenius Kabi, Mylan, Sagent Pharmaceuticals, Bionova Scientific, Macleods Pharmaceuticals, Johnlee Pharmaceuticals, Xinya Pharm, PKU HealthCare, United Laboratories, CSPC Group, Zhejiang Hisun Pharmaceutical, Luoxin Pharmaceutical, Hainan Haiyao Co., Ltd., Shenzhen Haibin Pharmaceutical, Chongqin Shenghuaxi

What are the Application segmentation covered in the Meropenem Injection Market report?

Ans: The Applications covered in the Meropenem Injection Market report are Hospital, Clinics, Others

What are the Type segmentation covered in the Meropenem Injection Market report?

Ans: The Types covered in the Meropenem Injection Market report are 0.25g/vial, 0.5g/vial, 1g/vial

1 Meropenem Injection Market Overview
1.1 Product Definition
1.2 Meropenem Injection by Type
1.2.1 Global Meropenem Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.25g/vial
1.2.3 0.5g/vial
1.2.4 1g/vial
1.3 Meropenem Injection by Application
1.3.1 Global Meropenem Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Meropenem Injection Market Size Estimates and Forecasts
1.4.1 Global Meropenem Injection Revenue 2020-2031
1.4.2 Global Meropenem Injection Sales 2020-2031
1.4.3 Global Meropenem Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Meropenem Injection Market Competition by Manufacturers
2.1 Global Meropenem Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Meropenem Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Meropenem Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Meropenem Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meropenem Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meropenem Injection, Product Type & Application
2.7 Global Key Manufacturers of Meropenem Injection, Date of Enter into This Industry
2.8 Global Meropenem Injection Market Competitive Situation and Trends
2.8.1 Global Meropenem Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meropenem Injection Players Market Share by Revenue
2.8.3 Global Meropenem Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meropenem Injection Market Scenario by Region
3.1 Global Meropenem Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Meropenem Injection Sales by Region: 2020-2031
3.2.1 Global Meropenem Injection Sales by Region: 2020-2025
3.2.2 Global Meropenem Injection Sales by Region: 2026-2031
3.3 Global Meropenem Injection Revenue by Region: 2020-2031
3.3.1 Global Meropenem Injection Revenue by Region: 2020-2025
3.3.2 Global Meropenem Injection Revenue by Region: 2026-2031
3.4 North America Meropenem Injection Market Facts & Figures by Country
3.4.1 North America Meropenem Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Meropenem Injection Sales by Country (2020-2031)
3.4.3 North America Meropenem Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meropenem Injection Market Facts & Figures by Country
3.5.1 Europe Meropenem Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Meropenem Injection Sales by Country (2020-2031)
3.5.3 Europe Meropenem Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meropenem Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Meropenem Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Meropenem Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Meropenem Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meropenem Injection Market Facts & Figures by Country
3.7.1 Latin America Meropenem Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Meropenem Injection Sales by Country (2020-2031)
3.7.3 Latin America Meropenem Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meropenem Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Meropenem Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Meropenem Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Meropenem Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meropenem Injection Sales by Type (2020-2031)
4.1.1 Global Meropenem Injection Sales by Type (2020-2025)
4.1.2 Global Meropenem Injection Sales by Type (2026-2031)
4.1.3 Global Meropenem Injection Sales Market Share by Type (2020-2031)
4.2 Global Meropenem Injection Revenue by Type (2020-2031)
4.2.1 Global Meropenem Injection Revenue by Type (2020-2025)
4.2.2 Global Meropenem Injection Revenue by Type (2026-2031)
4.2.3 Global Meropenem Injection Revenue Market Share by Type (2020-2031)
4.3 Global Meropenem Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Meropenem Injection Sales by Application (2020-2031)
5.1.1 Global Meropenem Injection Sales by Application (2020-2025)
5.1.2 Global Meropenem Injection Sales by Application (2026-2031)
5.1.3 Global Meropenem Injection Sales Market Share by Application (2020-2031)
5.2 Global Meropenem Injection Revenue by Application (2020-2031)
5.2.1 Global Meropenem Injection Revenue by Application (2020-2025)
5.2.2 Global Meropenem Injection Revenue by Application (2026-2031)
5.2.3 Global Meropenem Injection Revenue Market Share by Application (2020-2031)
5.3 Global Meropenem Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Meropenem Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AuroMedics
6.2.1 AuroMedics Company Information
6.2.2 AuroMedics Description and Business Overview
6.2.3 AuroMedics Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AuroMedics Meropenem Injection Product Portfolio
6.2.5 AuroMedics Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Company Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sandoz Meropenem Injection Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Amneal Pharmaceuticals
6.4.1 Amneal Pharmaceuticals Company Information
6.4.2 Amneal Pharmaceuticals Description and Business Overview
6.4.3 Amneal Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Amneal Pharmaceuticals Meropenem Injection Product Portfolio
6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5 Sumitomo Dainippon Pharma
6.5.1 Sumitomo Dainippon Pharma Company Information
6.5.2 Sumitomo Dainippon Pharma Description and Business Overview
6.5.3 Sumitomo Dainippon Pharma Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio
6.5.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Company Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fresenius Kabi Meropenem Injection Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Mylan
6.7.1 Mylan Company Information
6.7.2 Mylan Description and Business Overview
6.7.3 Mylan Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mylan Meropenem Injection Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Sagent Pharmaceuticals
6.8.1 Sagent Pharmaceuticals Company Information
6.8.2 Sagent Pharmaceuticals Description and Business Overview
6.8.3 Sagent Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sagent Pharmaceuticals Meropenem Injection Product Portfolio
6.8.5 Sagent Pharmaceuticals Recent Developments/Updates
6.9 Bionova Scientific
6.9.1 Bionova Scientific Company Information
6.9.2 Bionova Scientific Description and Business Overview
6.9.3 Bionova Scientific Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bionova Scientific Meropenem Injection Product Portfolio
6.9.5 Bionova Scientific Recent Developments/Updates
6.10 Macleods Pharmaceuticals
6.10.1 Macleods Pharmaceuticals Company Information
6.10.2 Macleods Pharmaceuticals Description and Business Overview
6.10.3 Macleods Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Macleods Pharmaceuticals Meropenem Injection Product Portfolio
6.10.5 Macleods Pharmaceuticals Recent Developments/Updates
6.11 Johnlee Pharmaceuticals
6.11.1 Johnlee Pharmaceuticals Company Information
6.11.2 Johnlee Pharmaceuticals Description and Business Overview
6.11.3 Johnlee Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Johnlee Pharmaceuticals Meropenem Injection Product Portfolio
6.11.5 Johnlee Pharmaceuticals Recent Developments/Updates
6.12 Xinya Pharm
6.12.1 Xinya Pharm Company Information
6.12.2 Xinya Pharm Description and Business Overview
6.12.3 Xinya Pharm Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Xinya Pharm Meropenem Injection Product Portfolio
6.12.5 Xinya Pharm Recent Developments/Updates
6.13 PKU HealthCare
6.13.1 PKU HealthCare Company Information
6.13.2 PKU HealthCare Description and Business Overview
6.13.3 PKU HealthCare Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 PKU HealthCare Meropenem Injection Product Portfolio
6.13.5 PKU HealthCare Recent Developments/Updates
6.14 United Laboratories
6.14.1 United Laboratories Company Information
6.14.2 United Laboratories Description and Business Overview
6.14.3 United Laboratories Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 United Laboratories Meropenem Injection Product Portfolio
6.14.5 United Laboratories Recent Developments/Updates
6.15 CSPC Group
6.15.1 CSPC Group Company Information
6.15.2 CSPC Group Description and Business Overview
6.15.3 CSPC Group Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CSPC Group Meropenem Injection Product Portfolio
6.15.5 CSPC Group Recent Developments/Updates
6.16 Zhejiang Hisun Pharmaceutical
6.16.1 Zhejiang Hisun Pharmaceutical Company Information
6.16.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.16.3 Zhejiang Hisun Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio
6.16.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.17 Luoxin Pharmaceutical
6.17.1 Luoxin Pharmaceutical Company Information
6.17.2 Luoxin Pharmaceutical Description and Business Overview
6.17.3 Luoxin Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Luoxin Pharmaceutical Meropenem Injection Product Portfolio
6.17.5 Luoxin Pharmaceutical Recent Developments/Updates
6.18 Hainan Haiyao Co., Ltd.
6.18.1 Hainan Haiyao Co., Ltd. Company Information
6.18.2 Hainan Haiyao Co., Ltd. Description and Business Overview
6.18.3 Hainan Haiyao Co., Ltd. Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio
6.18.5 Hainan Haiyao Co., Ltd. Recent Developments/Updates
6.19 Shenzhen Haibin Pharmaceutical
6.19.1 Shenzhen Haibin Pharmaceutical Company Information
6.19.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
6.19.3 Shenzhen Haibin Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio
6.19.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.20 Chongqin Shenghuaxi
6.20.1 Chongqin Shenghuaxi Company Information
6.20.2 Chongqin Shenghuaxi Description and Business Overview
6.20.3 Chongqin Shenghuaxi Meropenem Injection Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Chongqin Shenghuaxi Meropenem Injection Product Portfolio
6.20.5 Chongqin Shenghuaxi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meropenem Injection Industry Chain Analysis
7.2 Meropenem Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meropenem Injection Production Mode & Process Analysis
7.4 Meropenem Injection Sales and Marketing
7.4.1 Meropenem Injection Sales Channels
7.4.2 Meropenem Injection Distributors
7.5 Meropenem Injection Customer Analysis
8 Meropenem Injection Market Dynamics
8.1 Meropenem Injection Industry Trends
8.2 Meropenem Injection Market Drivers
8.3 Meropenem Injection Market Challenges
8.4 Meropenem Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Meropenem Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Meropenem Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Meropenem Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Meropenem Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Meropenem Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Meropenem Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Meropenem Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Meropenem Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Meropenem Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Meropenem Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Meropenem Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Meropenem Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meropenem Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meropenem Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meropenem Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Meropenem Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Meropenem Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Meropenem Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Meropenem Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Meropenem Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Meropenem Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Meropenem Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Meropenem Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Meropenem Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Meropenem Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Meropenem Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Meropenem Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Meropenem Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Meropenem Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Meropenem Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Meropenem Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Meropenem Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Meropenem Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Meropenem Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Meropenem Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Meropenem Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Meropenem Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Meropenem Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Meropenem Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Meropenem Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Meropenem Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Meropenem Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Meropenem Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Meropenem Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Meropenem Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Meropenem Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Meropenem Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Meropenem Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Meropenem Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Meropenem Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Meropenem Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Meropenem Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Meropenem Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Meropenem Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Meropenem Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Meropenem Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Meropenem Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Meropenem Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Meropenem Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Meropenem Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Meropenem Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Meropenem Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Meropenem Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Meropenem Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Meropenem Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Meropenem Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Meropenem Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Meropenem Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Meropenem Injection Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. AuroMedics Company Information
 Table 76. AuroMedics Description and Business Overview
 Table 77. AuroMedics Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AuroMedics Meropenem Injection Product
 Table 79. AuroMedics Recent Developments/Updates
 Table 80. Sandoz Company Information
 Table 81. Sandoz Description and Business Overview
 Table 82. Sandoz Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sandoz Meropenem Injection Product
 Table 84. Sandoz Recent Developments/Updates
 Table 85. Amneal Pharmaceuticals Company Information
 Table 86. Amneal Pharmaceuticals Description and Business Overview
 Table 87. Amneal Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Amneal Pharmaceuticals Meropenem Injection Product
 Table 89. Amneal Pharmaceuticals Recent Developments/Updates
 Table 90. Sumitomo Dainippon Pharma Company Information
 Table 91. Sumitomo Dainippon Pharma Description and Business Overview
 Table 92. Sumitomo Dainippon Pharma Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sumitomo Dainippon Pharma Meropenem Injection Product
 Table 94. Sumitomo Dainippon Pharma Recent Developments/Updates
 Table 95. Fresenius Kabi Company Information
 Table 96. Fresenius Kabi Description and Business Overview
 Table 97. Fresenius Kabi Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Fresenius Kabi Meropenem Injection Product
 Table 99. Fresenius Kabi Recent Developments/Updates
 Table 100. Mylan Company Information
 Table 101. Mylan Description and Business Overview
 Table 102. Mylan Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Mylan Meropenem Injection Product
 Table 104. Mylan Recent Developments/Updates
 Table 105. Sagent Pharmaceuticals Company Information
 Table 106. Sagent Pharmaceuticals Description and Business Overview
 Table 107. Sagent Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sagent Pharmaceuticals Meropenem Injection Product
 Table 109. Sagent Pharmaceuticals Recent Developments/Updates
 Table 110. Bionova Scientific Company Information
 Table 111. Bionova Scientific Description and Business Overview
 Table 112. Bionova Scientific Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bionova Scientific Meropenem Injection Product
 Table 114. Bionova Scientific Recent Developments/Updates
 Table 115. Macleods Pharmaceuticals Company Information
 Table 116. Macleods Pharmaceuticals Description and Business Overview
 Table 117. Macleods Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Macleods Pharmaceuticals Meropenem Injection Product
 Table 119. Macleods Pharmaceuticals Recent Developments/Updates
 Table 120. Johnlee Pharmaceuticals Company Information
 Table 121. Johnlee Pharmaceuticals Description and Business Overview
 Table 122. Johnlee Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Johnlee Pharmaceuticals Meropenem Injection Product
 Table 124. Johnlee Pharmaceuticals Recent Developments/Updates
 Table 125. Xinya Pharm Company Information
 Table 126. Xinya Pharm Description and Business Overview
 Table 127. Xinya Pharm Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Xinya Pharm Meropenem Injection Product
 Table 129. Xinya Pharm Recent Developments/Updates
 Table 130. PKU HealthCare Company Information
 Table 131. PKU HealthCare Description and Business Overview
 Table 132. PKU HealthCare Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. PKU HealthCare Meropenem Injection Product
 Table 134. PKU HealthCare Recent Developments/Updates
 Table 135. United Laboratories Company Information
 Table 136. United Laboratories Description and Business Overview
 Table 137. United Laboratories Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. United Laboratories Meropenem Injection Product
 Table 139. United Laboratories Recent Developments/Updates
 Table 140. CSPC Group Company Information
 Table 141. CSPC Group Description and Business Overview
 Table 142. CSPC Group Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. CSPC Group Meropenem Injection Product
 Table 144. CSPC Group Recent Developments/Updates
 Table 145. Zhejiang Hisun Pharmaceutical Company Information
 Table 146. Zhejiang Hisun Pharmaceutical Description and Business Overview
 Table 147. Zhejiang Hisun Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Zhejiang Hisun Pharmaceutical Meropenem Injection Product
 Table 149. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
 Table 150. Luoxin Pharmaceutical Company Information
 Table 151. Luoxin Pharmaceutical Description and Business Overview
 Table 152. Luoxin Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Luoxin Pharmaceutical Meropenem Injection Product
 Table 154. Luoxin Pharmaceutical Recent Developments/Updates
 Table 155. Hainan Haiyao Co., Ltd. Company Information
 Table 156. Hainan Haiyao Co., Ltd. Description and Business Overview
 Table 157. Hainan Haiyao Co., Ltd. Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Hainan Haiyao Co., Ltd. Meropenem Injection Product
 Table 159. Hainan Haiyao Co., Ltd. Recent Developments/Updates
 Table 160. Shenzhen Haibin Pharmaceutical Company Information
 Table 161. Shenzhen Haibin Pharmaceutical Description and Business Overview
 Table 162. Shenzhen Haibin Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Shenzhen Haibin Pharmaceutical Meropenem Injection Product
 Table 164. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
 Table 165. Chongqin Shenghuaxi Company Information
 Table 166. Chongqin Shenghuaxi Description and Business Overview
 Table 167. Chongqin Shenghuaxi Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Chongqin Shenghuaxi Meropenem Injection Product
 Table 169. Chongqin Shenghuaxi Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Meropenem Injection Distributors List
 Table 173. Meropenem Injection Customers List
 Table 174. Meropenem Injection Market Trends
 Table 175. Meropenem Injection Market Drivers
 Table 176. Meropenem Injection Market Challenges
 Table 177. Meropenem Injection Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meropenem Injection
 Figure 2. Global Meropenem Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Meropenem Injection Market Share by Type: 2024 & 2031
 Figure 4. 0.25g/vial Product Picture
 Figure 5. 0.5g/vial Product Picture
 Figure 6. 1g/vial Product Picture
 Figure 7. Global Meropenem Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Meropenem Injection Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinics
 Figure 11. Others
 Figure 12. Global Meropenem Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Meropenem Injection Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Meropenem Injection Sales (2020-2031) & (K Units)
 Figure 15. Global Meropenem Injection Average Price (US$/Unit) & (2020-2031)
 Figure 16. Meropenem Injection Report Years Considered
 Figure 17. Meropenem Injection Sales Share by Manufacturers in 2024
 Figure 18. Global Meropenem Injection Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Meropenem Injection Players: Market Share by Revenue in Meropenem Injection in 2024
 Figure 20. Meropenem Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Meropenem Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Meropenem Injection Sales Market Share by Country (2020-2031)
 Figure 23. North America Meropenem Injection Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Meropenem Injection Sales Market Share by Country (2020-2031)
 Figure 27. Europe Meropenem Injection Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Meropenem Injection Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Meropenem Injection Revenue Market Share by Region (2020-2031)
 Figure 35. China Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Meropenem Injection Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Meropenem Injection Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Meropenem Injection Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Meropenem Injection Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Meropenem Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Meropenem Injection by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Meropenem Injection by Type (2020-2031)
 Figure 57. Global Meropenem Injection Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Meropenem Injection by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Meropenem Injection by Application (2020-2031)
 Figure 60. Global Meropenem Injection Price (US$/Unit) by Application (2020-2031)
 Figure 61. Meropenem Injection Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India